Todd Rice

October 16, 2023

ICU antibiotics may be safe for kidneys

A Vanderbilt study found that two antibiotics thought to cause kidney failure in ICU patients with a severe bacterial infection, especially when combined with another antibiotic, may be safer for the kidneys than previously reported.

By Craig Boerner
Wesley Self, MD, MPH
February 2, 2023

Study of two sepsis interventions finds identical outcomes

Vanderbilt University Medical Center had a leading role in a large national study designed to compare two early interventions in the treatment of patients with sepsis, the body’s severe response to an uncontrolled infection.

By Nancy Humphrey
September 1, 2021

Alarming number of pregnant COVID-19 patients hospitalized in August

Vanderbilt University Hospital treated 39 pregnant patients hospitalized with active COVID-19 infections in August, 10 of whom were admitted to the intensive care unit (ICU).

By Emily Stembridge
February 5, 2021

Convalescent plasma improved survival in COVID-19 patients with blood cancers

Treatment with convalescent plasma vastly improved the survival rate of patients hospitalized for COVID-19 who also had hematologic malignances that compromise the immune system, according to new data released by the COVID-19 and Cancer Consortium (CCC19).

By Tom Wilemon
Tesha Akins
December 17, 2020

Vanderbilt University Medical Center begins giving COVID-19 vaccines to front-line caregivers

Vanderbilt University Medical Center began vaccinating its front-line caregivers for COVID-19 on Thursday, Dec. 17.

By VUMC News and Communications
October 16, 2020

Clinical trial to test HIV drugs to treat COVID-19

Vanderbilt University Medical Center, in collaboration with the University of Colorado and Beth Israel Deaconess Medical Center in Boston, is leading one of the first “telemedicine” clinical trials to test a potential treatment for COVID-19.

By Bill Snyder
August 21, 2020

VUMC awarded $34 million to lead nationwide convalescent plasma study

Vanderbilt University Medical Center has been awarded a one-year, $34-million grant by the National Center for Advancing Translational Sciences, part of the National Institutes of Health, to conduct a nationwide study of “convalescent plasma” as a treatment for COVID-19.
By Bill Snyder
July 23, 2020

Rice named to new leadership role for VICTR operations

Todd Rice, MD, MSc, has been appointed vice president for Clinical Trial Innovation and Operations in the Vanderbilt Institute for Clinical and Translational Research (VICTR).
By Bill Snyder
June 4, 2020

Remdesivir helps reduce COVID-19 recovery time: study

The investigational antiviral drug remdesivir can shorten the time to recovery in adults hospitalized with COVID-19, according to preliminary results of a clinical trial published last month in The New England Journal of Medicine.
By Bill Snyder
October 9, 2019

Vaccine study seeks to halt flu’s most severe side effects

Vanderbilt University Medical Center is leading a multicenter national study to evaluate the effectiveness of the influenza vaccine for preventing the flu’s most serious side effects — admission to an intensive care unit (ICU), organ failure and death.
By Nancy Humphrey
September 12, 2019

ECMO program expanding to more intensive care units

VUMC is expanding its ECMO program from its longtime home in the Cardiovascular Intensive Care Unit (CVICU) to the Medical (MICU) and Trauma Intensive Care units.
By Matt Batcheldor
October 1, 2015

Many hands help make wedding dream come true

Their wedding date was just weeks away when Caleb Hanby and his fiancée Bethany Davidson rushed to Vanderbilt University Medical Center last Thursday.
By VUMC News and Communications
March 12, 2015

Panel examines real-world role of pragmatic research trials

The question of what’s different about pragmatic research was aired in a well-attended panel discussion last week in Light Hall sponsored by the Vanderbilt Center for Health Services Research and the Mid-South Clinical Data Research Network (CDRN).
By Paul Govern
1 2